Analyst Research Report Snapshot

Title:

Fresenius SE & Co. KGaA

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

04 Aug 2015

Pages:

46

Type:

AcrobatPDF

Companies referenced:

FREG.DE

Available for Immediate Download
Summary:

Fresenius SE & Co. KGaA - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Fresenius SE & Co. KGaA required for business and competitor intelligence needs - A study of the major internal and external factors affecting Fresenius SE & Co. KGaA in the form of a SWOT analysis - An in-depth view of the business model of Fresenius SE & Co. KGaA including a breakdown and examination of key business segments - Intelligence on Fresenius SE & Co. KGaA’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Fresenius SE & Co. KGaA, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Fresenius SE & Co. KGaA (Fresenius or 'the group'), the holding company of the Fresenius Group, is a leading global provider of products and services for dialysis, hospitals and outpatient medical care. The group operates in Europe, North America, Latin America, Asia Pacific, and Africa. It is headquartered in Bad Homburg, Germany, and employed 178,337 people as on December 31, 2013. The company recorded revenues of E20,331 million (approximately $26,999.6 million) during the financial year ended December 2013 (FY2013), an increase of 5.4% over FY2012. The operating profit of the company was E2,991 million (approximately $3,972 million) in FY2013, an increase of 0.3% over FY2012. The net profit of the company was E1,738 million (approximately $2,308.1 million) in FY2013, an increase of 0.3% over FY2012. Reasons to Purchase: - Gain understanding of Fresenius SE & Co. KGaA and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Fresenius SE & Co. KGaA as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Fresenius SE & Co. KGaA’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.